Pages

Thursday, April 24, 2014

CRISPR Therapeutics Raises $25 Million in Series A Financing and...

CRISPR Therapeutics, a biopharmaceutical company focused on the breakthrough gene-editing technology CRISPR-Cas9, has raised $25 million in a series A investment from Versant Ventures.

http://ift.tt/1psmSat

No comments:

Post a Comment